GREGORY GLADISH to Lung Neoplasms
This is a "connection" page, showing publications GREGORY GLADISH has written about Lung Neoplasms.
Connection Strength
0.471
-
Prognostic value of positron emission tomography/computed tomography findings in limited-stage small cell lung cancer before chemoradiation therapy. Am J Clin Oncol. 2014 Feb; 37(1):77-80.
Score: 0.094
-
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept. Cell Rep Med. 2024 Mar 19; 5(3):101463.
Score: 0.048
-
Incidence and Onset of Severe Cardiac Events After Radiotherapy for Esophageal Cancer. J Thorac Oncol. 2020 10; 15(10):1682-1690.
Score: 0.037
-
Revised Modified RECIST Criteria in Malignant Pleural Mesothelioma (Version 1.1): A Step Forward in a Long Race. J Thorac Oncol. 2018 07; 13(7):871-873.
Score: 0.032
-
Cardiac ?8F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy. Radiother Oncol. 2013 Oct; 109(1):82-8.
Score: 0.023
-
Large decreases in standardized uptake values after definitive radiation are associated with better survival of patients with locally advanced non-small cell lung cancer. J Nucl Med. 2012 Feb; 53(2):225-33.
Score: 0.020
-
The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): a completed reference database of lung nodules on CT scans. Med Phys. 2011 Feb; 38(2):915-31.
Score: 0.019
-
The National Lung Screening Trial: overview and study design. Radiology. 2011 Jan; 258(1):243-53.
Score: 0.019
-
Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer. Cancer. 2010 May 15; 116(10):2401-8.
Score: 0.018
-
Phase 1b study of motesanib, an oral angiogenesis inhibitor, in combination with carboplatin/paclitaxel and/or panitumumab for the treatment of advanced non-small cell lung cancer. Clin Cancer Res. 2010 Jan 01; 16(1):279-90.
Score: 0.018
-
Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer. J Thorac Oncol. 2008 Apr; 3(4):351-7.
Score: 0.016
-
Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management. Radiographics. 2008 Mar-Apr; 28(2):551-60; quiz 620.
Score: 0.016
-
Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response. Radiographics. 2008 Mar-Apr; 28(2):561-72.
Score: 0.016
-
Development of pulmonary arteriovenous communications within pulmonary metastases after chemotherapy. J Thorac Oncol. 2007 Mar; 2(3):243-6.
Score: 0.015
-
Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer. J Thorac Imaging. 2006 Aug; 21(3):205-12.
Score: 0.014
-
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer. Cancer. 2005 Dec 01; 104(11):2449-56.
Score: 0.013
-
Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer. Radiology. 2005 Jul; 236(1):271-5.
Score: 0.013
-
Integrated positron emission tomography/computed tomography in patients with non-small cell lung cancer: normal variants and pitfalls. J Comput Assist Tomogr. 2005 Mar-Apr; 29(2):205-9.
Score: 0.013
-
Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol. 2003 Jul 01; 21(13):2574-82.
Score: 0.011
-
Hepatic segments II and III mimicking a lung mass: diagnosis of a normal variant using reformatted multiplanar CT images. J Comput Assist Tomogr. 2002 May-Jun; 26(3):365-7.
Score: 0.010
-
Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods. Radiology. 2015 Jul; 276(1):82-90.
Score: 0.006